In this assay, we used murine melanoma B16F10 cells, Lewis lung carcinoma LL/2 cells and colon carcinoma CT26 cells to generate tumor models to assess the anti-tumor effects of the FAP-modified tumor cells. This evidence concerns the gene FAP and Carcinoma, Lewis Lung.